Recent Updates
Recently added Catalysts
LEXX

Filed by newsfilecorp.com ViPova TM by Lexaria Launches National Sales Initiative Kelowna, BC /

Key Takeaway: ViPovaTM by Lexaria Launches National Sales Initiative Kelowna, BC / February 23, 2015 / Lexaria, Corp. (LXRP) (CSE:LXX) (the Company ) announces that ViPovaTM by Lexaria has launched a national US initiative designed to assist Americans to simultaneously achieve two importa

Full Press Release Details

ViPovaTM by Lexaria Launches
National Sales Initiative
Kelowna, BC / February 23, 2015 / Lexaria, Corp. (LXRP)
(CSE:LXX) (the Company ) announces that ViPovaTM by Lexaria has
launched a national US initiative designed to assist Americans to simultaneously
achieve two important objectives:
1) To try new ViPova TM CBD-infused tea, hold a TEA PARTY in your home or office. The President of ViPova or another Lexaria/ViPova member will personally visit with you; share ViPova TM Tea amongst the group; provide information; answer questions; and, invite participants to become Channel Partner Distributors.
Contact ViPova TM through our website or by email at teaparty@vipova.com , to make your request to host a ViPova TM TEA PARTY. In order to qualify to host your TEA PARTY, certain criteria, not limited to the following, must be met: a minimum of 12 people over the age of 21 must attend the TEA PARTY. We will consider all TEA PARTY requests and follow up with you regarding possible dates and schedules, as we roam across the country.
2) Not only will TEA PARTY participants have a chance to enjoy great-tasting ViPova TM tea with no obligation, they will also be able to apply on the spot at these unique events to become authorized CHANNEL PARTNER Distributors of ViPova TM products. In addition to receiving extensive, industry leading product training, distributors will have the potential to earn an exciting supplementary income selling ViPova TM products. Persons wishing to become ViPova TM distributors can also apply by downloading an application form available at www.vipova.com A limited number of CHANNEL PARTNER distributorships will be available in each state in the country. Interested distributors or TEA PARTY hosts can also email us at teaparty@vipova.com with your contact information and we will respond asap.
ViPovaTM by Lexaria is the country s first
CBD/Lipid-infused tea, and we are excited to launch this initiative to establish
the nation s best trained direct sales force for this highly anticipated brand
Consumers across all 50 states can now buy America s FIRST
product that uses patent-pending technology to infuse CBDs within lipids for the
most comforting and effective experience possible. As 2015 unfolds,
ViPovaTM expects to offer additional products to its lineup.
As well, the Lexaria EnergyTM brand will also be
launched in the first half of 2015 and ViPovaTM CHANNEL PARTNER
Distributors will automatically be eligible to also sell the full line of
Lexaria EnergyTM brand products as they are unveiled.
Broadening our product offerings, combined with early geographic sales
advantages, will make this opportunity to quickly acquire Distributor rights
particularly rewarding.
The www.vipova.com website
and our toll-free phone lines are taking tea orders. Customers can call
1-888-976-8482 from 9AM to 7PM EST Mon-Fri and we accept most major credit
For a limited time only, our two introductory offers remain
valid: on your first order, please enjoy free shipping and a coupon good for 30%
off your subsequent order, regardless of order size.
Lexaria's shares are quoted in the USA with
symbol LXRP and in Canada with symbol LXX. The company searches for projects
that could provide potential above-market returns. www.lexarienergy.com
legal CBD oil extracts, grown from legal hemp in locations where it is legal to
do so, in ViPovaTM-branded tea. ViPovaTM uses its
patent-pending process to infuse concentrated amounts of CBD within lipids in
its tea, providing more bioactivity and comfort to the body during the
absorption process. Only ViPovaTM has this ground-breaking technology
for CBD/lipid infusion. www.vipova.com
FOR FURTHER INFORMATION PLEASE CONTACT:
FORWARD-LOOKING STATEMENTS
This release includes forward-looking statements. Statements
which are not historical facts are forward-looking statements. The Company makes
forward-looking public statements concerning its expected future financial
position, results of operations, cash flows, financing plans, business strategy,
products and services, competitive positions, growth opportunities, plans and
objectives of management for future operations, including statements that
include words such as "anticipate," "if," "believe," "plan," "estimate,"
"expect," "intend," "may," "could," "should," "will," and other similar
expressions are forward-looking statements. Such forward-looking statements are
estimates reflecting the Company's best judgment based upon current information
and involve a number of risks and uncertainties, and there can be no assurance
that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk
and there is no assurance that the Company will be able to raise required
working capital. Current oil and gas production rates may not be sustainable and
targeted production rates may not occur. Factors which could cause actual
results to differ materially from those estimated by the Company include, but
are not limited to, government regulation, managing and maintaining growth, the
effect of adverse publicity, litigation, competition and other factors which may
be identified from time to time in the Company's public announcements and
filings. There is no assurance that the medical marijuana, CBD sector, or
alternative health businesses will provide any benefit to Lexaria, or that the
Company will experience any growth through participation in these sectors. There
is no assurance that existing capital is sufficient for the Company's needs or
that it will need to attempt to raise additional capital. There is no assurance
that any cannabinoid-based product will promote, assist, or maintain any
beneficial human health conditions whatsoever. No statement herein has been
evaluated by the Food and Drug Administration (FDA). ViPovaTM
products are not intended to diagnose, treat, cure or prevent any disease.
The CSE has not reviewed and does not accept responsibility
for the adequacy or accuracy of this release.
Last updated: Feb 23, 2015